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Abstract 
 
This study was conducted in the department of Biochemistry 
faculty of Veterinary Medicine University of Khartoum, to evaluate the 
influences of feeding high saturated fat diet versus feeding high 
cholesterol diet on blood cholesterol and to detect the presence of 
atherogenic changes in tissues of heart and Liver in rats. 
Thirty Wister albino rats were used in this study. The rats were divided 
into three groups named A, B and C of ten rats each. Group A was given 
basal diet only and served as control.  Group B received the rats basal 
diet mixed homogeneously with cholesterol powder as 2% of the diet. 
Group C received saturated fats mixed as 14% of the basal diet. The 
experimental period extended for three months. 
Blood samples were collected after the first, second and third month from 
all groups, to estimate the levels of cholesterol and its fractions together 
with the triglycerides concentration. Then all rats were scarified and 
tissues were collected for histopathology.  
When the three groups were compared together, group B showed 
significantly (P> 0.05) higher levels of total cholesterol and LDL-C 
compared to the control group for all readings. Whereas, VLDL-C and 
TAG reported significantly (p> 0.05) Lower levels compared to the 
control group for all readings. The HDL-C showed significantly (P> 0. 
05) higher values after the first and third month but after the second 
month it showed significantly (P> 0.05) Lower value compared to the 
control group. 
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In group C the levels of total cholesterol, LDL–C, HDL-C, VLDL-C and 
TAG were non–significantly different for the three readings, with 
numerically higher values for the total cholesterol and the LDL-C in all 
readings compared to the control group. The results obtained from this 
work, indicated that high dietary cholesterol affect plasma lipid profile 
concentration while feeding high saturated fats showed non significant 
changes on lipid profile of the plasma. 
For the histopathological findings in group B the heart showed edema of 
cardiac muscles, zenker necrosis, hyalinization and thickness of blood 
vessels and presence of cholesterol cleft while heart in group C showed 
hyalinization of cardiac muscles fiber, edema, infiltration of RBCs in the 
heart muscle, blood vessels thickness and mild monocular cellular 
infiltration with zenker necrosis. 
In group B, the liver showed vacuolization , dilatation of sinusoid, 
necrosis and disorganization of hepatocytes   .while liver in group C 
showed vacuolization of hepatic cytoplasm, congestions of veins, of 
sinusoids, bile duct proliferation, kuffer cells were prominent, congestion 
of central veins and extra hepatic hemopoisis and focal  infiltration of  
inflammatory cells and necrosis. So histopathological findings indicated 
that both high dietary cholesterol and high dietary saturated fats showed 
clear histopathological changes in tissues of the heart and liver. 
The histopathological changes observed for both treated groups, recorded 
more signs of inflammation in the group received high saturated fat diet. 
The control showed healthy histopathology tissues. 
The present study concluded that though high cholesterol diet 
significantly influenced the blood cholesterol and triglyceride levels, 
 
x
whereas histopathological changes showed that both high cholesterol diet 
and high saturated fat diet resulted in clear changes to both treated groups 
with more inflammatory signs in group received saturated fats.  
So future studies includes more number of animals and to be subjected to 
more experimental period may give clear picture about the actual effect 
of both treatments also other atherogenic indices should be measured to 
evaluate which is the most responsible of inducing atherosclerosis is it 
the high cholesterol diet or the high saturated fat diet. 
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 اﻟﻤﺴﺘﺨﻠﺺ
 
، آﻠﻴﺔ اﻟﻄﺐ اﻟﺒﻴﻄﺮي ﺟﺎﻣﻌﺔ اﻟﺨﺮﻃﻮمﺗﻢ اﻧﺠﺎز هﺬﻩ اﻟﺪراﺳﺔ ﺑﻘﺴﻢ اﻟﻜﻴﻤﻴﺎء اﻟﺤﻴﻮﻳﺔ ﻓﻲ 
وﻗﺪ هﺪﻓﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﺘﻘﻴﻴﻢ أﺛﺮ اﻟﻜﻮﻟﻴﺴﺘﺮول واﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﻓﻲ اﻟﻐﺬاء ﻋﻠﻲ ﻣﺴﺘﻮﻳﺎت 
ﺪات ﺠﻠﺴﺮﻳ، واﻟﻓﺔ، اﻟﻼﻳﺒﻮﺑﺮوﺗﻴﻦ ﻋﺎﻟﻲ اﻟﻜﺜﺎﻓﺔاﻟﻜﻮﻟﻴﺴﺘﺮول اﻟﻜﻠﻲ ، اﻟﻼﻳﺒﻮﺑﺮوﺗﻴﻦ ﻣﻨﺨﻔﺾ اﻟﻜﺜﺎ
  .ت اﻟﻤﺮﺿﻴﺔ ﻋﻠﻲ ﺑﻨﻴﺔ اﻟﻘﻠﺐ واﻟﻜﺒﺪهﺬا ﺑﺎﻹﺿﺎﻓﺔ ﻟﺪراﺳﺔ اﻟﺘﻐﻴﺮا. اﻟﺜﻼﺛﻴﺔ ﻓﻲ دم اﻟﻔﺌﺮان
وآﻞ ﻣﺠﻤﻮﻋﺔ ﺗﺤﺘﻮي ﻋﻠﻲ ﻋﺸﺮ ( ج)، (ب)، ( أ)ﻴﻤﻬﻢ إﻟﻲ ﺛﻼث ﻣﺠﻤﻮﻋﺎت ﺛﻼﺛﻮن ﻓﺄرًا ﺗﻢ ﺗﻘﺴ
، ﻴﺖ هﺬﻩ اﻟﻤﺠﻤﻮﻋﺔ اﻟﻮﺟﺒﺔ اﻷﺳﺎﺳﻴﺔﺗﻤﺜﻞ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ وأﻋﻄ( أ)ﻋﺔ ﻮﻓﺌﺮان ﺣﻴﺚ آﺎﻧﺖ اﻟﻤﺠﻤ
أﻋﻄﻴﺖ ( ج)، واﻟﻤﺠﻤﻮﻋﺔ آﻮﻟﻴﺴﺘﺮول% 2أﻋﻄﻴﺖ اﻟﻮﺟﺒﺔ اﻷﺳﺎﺳﻴﺔ ﺑﺈﺿﺎﻓﺔ ( ب)ﻤﺠﻤﻮﻋﺔ واﻟ
  .واﻣﺘﺪت ﻓﺘﺮة اﻟﺘﺠﺮﺑﺔ ﻟﺜﻼﺛﺔ أﺷﻬﺮدهﻮن ﻣﺸﺒﻌﺔ % 41اﻟﻮﺟﺒﺔ اﻷﺳﺎﺳﻴﺔ ﺑﺈﺿﺎﻓﺔ 
، ﺷﻬﺮﻳﻦ وﺛﻼﺛﺔ أﺷﻬﺮ ﻟﻜﻞ اﻟﻤﺠﻤﻮﻋﺎت ﺑﻐﺮض ﻗﻴﺎس ﻧﺴﺒﺔ أﺧﺬت ﻋﻴﻨﺎت ﻣﻦ اﻟﺪم ﺑﻌﺪ ﺷﻬﺮ
ﻟﻘﻴﺎس ﻣﺴﺘﻮي ﻓﻲ اﻟﺒﺮوﺗﻴﻨﺎت اﻟﺪهﻨﻴﺔ ﺑﺎﻹﺿﺎﻓﺔ  اﻟﻜﻮﻟﻴﺴﺘﺮول اﻟﻜﻠﻲ وﻣﺴﺘﻮى اﻟﻜﻮﻟﻴﺴﺘﺮول
ﺗﻢ ذﺑﺢ ﺟﻤﻴﻊ اﻟﻔﺌﺮان وﺟﻤﻊ اﻟﻌﻴﻨﺎت ﻣﻦ أﻧﺴﺠﺔ اﻟﻘﻠﺐ واﻟﻜﺒﺪ ﺑﻐﺮض دراﺳﺔ . اﻟﺠﻠﺴﺮﻳﺪات اﻟﺜﻼﺛﻴﺔ
  .اﻟﺘﻐﻴﺮات اﻟﻤﺮﺿﻴﺔ ﻓﻴﻬﺎ
ﻋﻨﺪ ﻣﻘﺎرﻧﺔ اﻟﺜﻼث ﻣﺠﻤﻮﻋﺎت ﻣﻊ ﺑﻌﻀﻬﺎ وﺟﺪ أن ﻣﺴﺘﻮﻳﺎت اﻟﻜﻮﻟﻴﺴﺘﺮول اﻟﻜﻠﻲ وآﻮﻟﻴﺴﺘﺮول 
( ب)ﻓﻲ ااﻟﻤﺠﻤﻮﻋﺔ  )50.0 <P( ﺜﺎﻓﺔ ﻗﺪ ﺳﺠﻠﺖ زﻳﺎدة ﻣﻌﻨﻮﻳﺔﻮﺑﺮوﺗﻴﻦ ﻣﻨﺨﻔﺾ اﻟﻜﻳﺒاﻟﻼ
ﻮﺑﺮوﺗﻴﻦ ﻳﺒ، وﺳﺠﻞ ﻣﺴﺘﻮى اﻟﻜﻮﻟﻴﺴﺘﺮول ﻓﻲ اﻟﻼﻞ اﻟﻘﺮاءاتﺑﺎﻟﻤﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ ﻟﻜ
 )50.0 <P(اﻟﻤﻨﺨﻔﺾ اﻟﻜﺜﺎﻓﺔ ﺟﺪًا واﻟﺠﻠﺴﺮﻳﺪات اﻟﺜﻼﺛﻴﺔ ﻟﻨﻔﺲ اﻟﻤﺠﻤﻮﻋﺔ اﻧﺨﻔﺎﺿًﺎ ﻣﻌﻨﻮﻳﺎ 
ﻓﻲ اﻟﺸﻬﺮ اﻷول واﻟﺜﺎﻟﺚ  )50.0 <P(ة ﻣﻌﻨﻮﻳﺔ زﻳﺎدﻮﺑﺮوﺗﻴﻦ ﻋﺎﻟﻲ اﻟﻜﺜﺎﻓﺔ ﻳﺒﻣﻊ اﻟﻼﺑﺎﻟﻤﻘﺎرﻧﺔ 
  . اﻟﺜﺎﻧﻲ ﻣﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ ﺑﻌﺪ اﻟﺸﻬﺮ )50.0 <P(وﺳﺠﻞ اﻧﺨﻔﺎﺿًﺎ ﻣﻌﻨﻮﻳًﺎ 
ﻟﻢ ﻳﻜﻦ هﻨﺎﻟﻚ ﻓﺮق ﻣﻌﻨﻮي ﻓﻲ ﻣﺴﺘﻮﻳﺎت اﻟﻜﻮﻟﻴﺴﺘﺮول اﻟﻜﻠﻲ وآﻠﻴﺴﺘﺮول ( ج) ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ
اﻟﻼﻳﺒﻮﺑﺮوﺗﻴﻨﺎت واﻟﺠﻠﺴﺮﻳﺪات اﻟﺜﻼﺛﻴﺔ ﻟﻠﻘﺮاءات اﻟﺜﻼث ﺑﺎﻟﻤﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ ﻣﻊ وﺟﻮد 
ﻮﺑﺮوﺗﻴﻦ ﻋﺎﻟﻲ اﻟﻜﺜﺎﻓﺔ ﻟﻜﻞ ﻳﺒزﻳﺎدة ﻓﻲ ﻣﺴﺘﻮﻳﺎت اﻟﻜﻮﻟﻴﺴﺘﺮول اﻟﻜﻠﻲ واﻟﻜﻮﻟﻴﺴﺘﺮول ﻓﻲ اﻟﻼ
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وﻳﺴﺘﻨﺘﺞ ﻣﻦ هﺬا أن زﻳﺎدة اﻟﻜﻮﻟﻴﺴﺘﺮول ﻓﻲ اﻟﻐﺬاء ﺗﺆﺛﺮ  .ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢ اﻟﻘﺮاءات ﺑﺎﻟﻤﻘﺎرﻧﺔ 
  .ﻋﻠﻲ ﻣﺴﺘﻮﻳﺎت اﻟﺪهﻮن ﻓﻲ اﻟﺪم ﺑﻴﻨﻤﺎ ﻧﺠﺪ أن زﻳﺎدة اﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﻻ ﺗﺆﺛﺮ
ﻣﺮﺿﻴﺔ واﺿﺤﺔ ﻓﻲ ﺗﻼﺣﻆ وﺟﻮد ﺗﻐﻴﺮات أﻣﺎ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﺘﻐﻴﺮات ﻓﻲ أﻧﺴﺠﺔ اﻟﻘﻠﺐ واﻟﻜﺒﺪ ﻓﻘﺪ 
ﺎت اﻟﻘﻠﺐ وﺟﻮد اﺳﺘﺴﻘﺎء ﻓﻲ اﻟﻌﻀﻠﺔ، ﻇﻬﺮت ﻋﻴﻨأ( ب)ﻔﻲ اﻟﻤﺠﻤﻮﻋﺔ ﻓ، ﻣﺠﻤﻮﻋﺘﻲ اﻟﻤﻌﺎﻟﺠﺔ
، ﺑﻴﻨﻤﺎ اﻟﺪﻣﻮﻳﺔ وﺗﺼﺪع آﻮﻟﺴﺘﺮوﻟﻲ ، زﻳﺎدة ﺳﻤﻚ ﺟﺪران اﻷوﻋﻴﺔﻧﺨﺮ، ﺗﻐﺒﺶ ﺷﻔﺎﻓﻴﺔ اﻟﻨﺴﻴﺞ
ب ، ﺗﺴﺮﻮد ﺗﻐﺒﺶ ﺷﻔﺎﻓﻴﺔ أﻟﻴﺎف ﻧﺴﻴﺞ اﻟﻘﻠﺐ، اﺳﺘﺴﻘﺎء ﻋﻀﻠﺔ اﻟﻘﻠﺐوﺟ( ج)ﺗﻼﺣﻆ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ 
ب ، ﻧﺨﺮ ﺑﺎﻹﺿﺎﻓﺔ ﻟﺘﺴﺮﺔ اﻟﺪﻣﻮﻳﺔزﻳﺎدة ﺳﻤﻚ ﺟﺪران اﻷوﻋﻴ، آﺮﻳﺎت اﻟﺪم اﻟﺤﻤﺮاء  ﻓﻲ اﻟﻌﻀﻠﺔ
  .ﺧﻼﻳﺎ أﺣﺎدﻳﺔ اﻟﻨﻮاة ﻓﻲ اﻟﻌﻀﻠﺔ
واﺧﺘﻼل ، ﻧﺨﺮ ن ﻓﺠﻮات، ﺗﻤﺪد اﻟﻤﻨﺤﻨﻴﺎت اﻟﺠﻴﺒﻴﺔﻮﻋﻴﻨﺎت اﻟﻜﺒﺪ ﺗﻜ أﻇﻬﺮت( ب)وﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ 
ات ﻓﻲ ﺳﻴﺘﻮﺑﻼزم اﻟﺨﻼﻳﺎ ﻓﻘﺪ ﺗﻼﺣﻆ ﺗﻜﻮن ﻓﺠﻮ( ج)، ﺑﻴﻨﻤﺎ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ ﻧﻈﺎم ﺧﻼﻳﺎ اﻟﻜﺒﺪ
ﻴﺒﻴﺔ، اﺣﺘﻘﺎن اﻷوردة، ﺗﺸﻌﺐ اﻟﻘﻨﺎة اﻟﺼﻔﺮاء، وﺑﺮوز ﻓﻲ ﺧﻼﻳﺎ اﻟﻜﺒﺪﻳﺔ، ﺗﻤﺪد ﻓﻲ اﻟﻤﻨﺤﻨﻴﺎت اﻟﺠ
    .ﺧﻼﻳﺎ ﻣﻠﺘﻬﺒﺔ ، ﻧﺨﺮ وارﺗﺸﺎحآﻮﻓﺮ
ﻣﻊ  ﺐ واﻟﻜﺒﺪ ﻟﻜﻠﺘﺎ ﻣﺠﻤﻮﻋﺘﻲ اﻟﻤﻌﺎﻟﺠﺔﻓﺈن هﻨﺎﻟﻚ ﺗﻐﻴﺮات ﻣﺮﺿﻴﺔ واﺿﺤﺔ ﻓﻲ أﻧﺴﺠﺔ اﻟﻘﻠ وﻟﻬﺬا 
وﺟﻮد ﻋﻼﻣﺎت ﻣﺮﺿﻴﺔ ﺑﺼﻮرة أوﺿﺢ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ اﻟﻤﻌﺎﻟﺠﺔ ﺑﺎﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﺑﻴﻨﻤﺎ أﻇﻬﺮت 
  .راﺳﺔ ﺳﻼﻣﺔ اﻷﻧﺴﺠﺔ ﻓﻲ ﻣﺠﻤﻮﻋﺔ اﻟﺘﺤﻜﻢاﻟﺪ
ﺆﺛﺮ ﺗﺄﺛﻴﺮا ﻣﻌﻨﻮﻳًﺎ ﻋﻠﻰ ﻣﺴﺘﻮﻳﺎت ﺗﺴﺘﺮول ﻓﻲ اﻟﻐﺬاء ﺧﻠﺼﺖ هﺬﻩ اﻟﺪراﺳﺔ اﻟﻰ أن زﻳﺎدة اﻟﻜﻮﻟﻴ
ﺴﺘﺮول واﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﻓﻲ اﻟﻐﺬاء اﻟﻜﻮﻟﻴن زﻳﺎدة واﻟﺠﻠﺴﻠﺮﻳﺪات اﻟﺜﻼﺛﻴﻪ ﻓﻲ اﻟﺪم وأ ﺴﺘﺮولاﻟﻜﻮﻟﻴ
ت ﺑﺼﻮرة أوﺿﺢ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻲ ﺗﺤﺪث ﺗﻐﻴﺮات ﻧﺴﻴﺠﻴﺔ ﻣﺮﺿﻴﺔ وﻗﺪ آﺎﻧﺖ هﺬﻩ اﻟﺘﻐﻴﺮا
  .أﻋﻄﻴﺖ دهﻮن ﻣﺸﺒﻌﺔ
ﺑﺔ وإﺧﻀﺎﻋﻬﺎ ﻟﻔﺘﺮة ﺗﺠﺮﺑﺔ ﻓﺎن اﻟﺪراﺳﺎت اﻟﻤﺴﺘﻘﺒﻠﻴﻪ ﻳﻤﻜﻦ ﻓﻴﻬﺎ زﻳﺎدة ﻋﺪد ﺣﻴﻮاﻧﺎت اﻟﺘﺠﺮ ﻪﻋﻠﻴ
رﺑﻤﺎ ﻳﻌﻄﻲ ﻧﺘﺎﺋﺞ أآﺜﺮ وﺿﻮﺣﺎ ﻋﻦ اﻷﺛﺮ اﻟﺤﻘﻴﻘﻲ ﻟﻠﻤﻌﺎﻟﺠﺘﻴﻦ آﺬﻟﻚ ﻓﺈﻧﻪ ﺑﺎﻻﻣﻜﺎن  ن ذﻟﻚﻷﻃﻮل أ
آﺜﺮ ﺗﺤﻔﻴﺰًا ﻟﺘﺼﻠﺐ اﻟﺸﺮاﻳﻴﻦ، زﻳﺎدة أﻳﻬﻤﺎ أﻗﻴﺎس ﻣﺘﻐﻴﺮات أﺧﺮى ﻣﻊ اﻟﺪهﻮن ﻟﻤﻌﺮﻓﺔ 
  .ﺴﺘﺮول أم زﻳﺎدة اﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﻓﻲ اﻟﻐﺬاءاﻟﻜﻮﻟﻴ
  
INTRODUCTION 
Lipids play many roles in biological systems. Like carbohydrates 
they are important sources of energy. In addition, they are essential 
components of membranes, they function as hormones, and they can serve 
as padding and thermal insulator.  Lipids are complex and heterogeneous 
groups of compounds that they defy rational classification.  However, 
despite their difference in structure, they share the property of being 
insoluble in water. Indeed they are so insoluble that they require special 
water-soluble lipid-protein complex (lipoprotein) for transport in the 
blood stream (Murray et al., 2003). 
Dyslipidaemia, which can range from hypercholesterolemia to hyper 
lipoproteinemia, is one of the many modifiable risk factors for coronary 
artery disease (CAD), stroke and peripheral vascular disease (Chong and 
Bachenheimer, 2000). Atherosclerosis is a disease of the intima of large 
and medium-sized arteries. Prominent among resultant intimal changes is 
the focal accumulation of lipid, particularly cholesterol and cholesteryl 
esters, in fibro fatty plaques known as atheroma (Varsheny and Sharma, 
1996). The atheroma narrows the arterial lumen, damage the underlying 
media and frequently become ulcerated and/or calcified, thus further 
narrowing the arterial lumen. In humans, this disease most commonly 
affects the abdominal aorta, coronary, iliac, femoral and cerebral arteries 
(Yoshikawa et al., 1997). 
Many researchers have suggested that the blood lipids play a key role in 
the immune defense system (Gallin et al., 1996). There is also a growing 
understanding that an inflammatory response of the arterial intima to 
injury is a crucial step in the genesis of atherosclerosis. and that infections 
may be one type of such injury (Ross, 1986). These two concepts are 
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difficult to harmonize with the low-density-lipoprotein (LDL) receptor 
hypothesis, according to which high LDL cholesterol is the most 
important cause of atherosclerosis. However, the many observations that 
conflict with the LDL receptor hypothesis, may be explained by the idea 
that high serum cholesterol and/or high LDL is protective against 
infection and atherosclerosis. Diets high in saturated fat are correlated 
with an increased incidence of atherosclerosis and coronary heart disease 
according to a number of studies (Kromhout et al., 1995). 
Controlled experimental studies have found that people consuming high 
saturated fat diets experience negative cholesterol profile changes 
(Lapinleimu et al., 1995). A 2003 meta-analysis published in the 
American Journal of Clinical Nutrition concluded that diets high in 
saturated fat negatively affected cholesterol profiles — predictors of a 
heart attack and other cardiovascular diseases (Abbey et al., 1994).  
Since the relation between dietary fat and atherosclerosis is a contentious 
field and there is no research indicating whether or not there is direct 
association between dietary cholesterol and dietary saturated fats with 
atherosclerosis, therefore, the aim of this study is to evaluate and compare 
the role of high dietary cholesterol and high dietary saturated fats in the 
development of atherosclerotic plaques by measuring the changes in the 
total blood cholesterol and its fractions together with the triacylglycerol in 
rats subjected to two types of treatments. Also the histopathological 
changes were planned to be examined for both cases in comparison to 
control. 
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CHAPTER ONE 
 
LITERATURE REVIEW 
1.1. Lipids:   
Plasma lipids are derived from food (exogenous) or synthesized in 
the body (endogenous). Lipids are relatively insoluble in water; they are 
carried in body fluids as soluble protein complexes known as lipoproteins 
(Murray et al., 2003). 
Four main classes of lipids can be recognized, from a metabolic stand 
point. These are cholesterol and its esters, triglycerides, phospholipids and 
fatty acids (Forrester et al., 1987). An understanding of the 
pathophysiology of plasma lipid metabolism is based on the concept of 
lipoproteins, the form in which lipids circulate in plasma. The principle 
functions of lipids are to act as energy stores and to serve as important 
structural component of cells. To fulfill these functions, lipids have to be 
transported in plasma from one tissue to another, from the intestine or the 
liver to other tissues such as muscular or adipose tissue, or from the other 
tissues to the liver (Bishop et al., 2000). There are complex mechanisms 
that control the release of lipids from tissues into plasma, and the uptake 
of lipids by the tissues from the plasma. Abnormalities of these 
mechanisms may be associated with the development of disease, 
particularly ischemic heart disease (Champe and Harvey, 1994). 
1.1.1 Cholesterol: 
Cholesterol is a lipid found in the cell membrane of all animal 
tissues, and it is transported in the blood plasma of all animals. 
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Cholesterol is also a sterol (a combination of steroid and alcohol). 
Because cholesterol is synthesized by all eukaryotes, most of the 
cholesterol is synthesized by the body and some has dietary origin. 
Cholesterol is more abundant in tissues which either synthesize more or 
have more abundant densely-packed membrane, for example, the liver, 
spinal cord and brain. It plays a central role in many biochemical 
processes, such as the composition of cell membrane and the synthesis of 
steroid hormones (Stryer, 1995).  
Cholesterol from the liver and intestine is transported in plasma. About 
75% esterified with fatty acids and the rest unesterified. It is taken up 
from plasma by different tissues. Its main route of metabolism is to bile 
acids, which are secreted into bile as conjugated with glycine or taurine. 
Unesterified cholesterol is also secreted into bile, and both undergo an 
entero-hepatic-circulation with some loss of cholesterol and bile acids 
occur daily in the faeces. Unlike that of triglycerides, plasma 
concentration of cholesterol does not rise after a fatty meal (Johnson et 
al., 1991). 
Since cholesterol is insoluble in blood, it is transported in the circulatory 
system within lipoproteins, which are complex spherical particles which 
have an exterior composed mainly of water-soluble proteins; fats and 
cholesterol are carried internally (Brunzell, 2008).  
1.1.2. Lipoproteins 
Lipoproteins are complexes of lipids and proteins held together by 
non-covalent bonds. The core is of insoluble (non-polar) cholesterol esters 
and triglycerides, surrounded by proteins (known as apolipoproteins), 
phospholipids and free cholesterol with their water soluble (polar) groups 
facing outwards. Clinically, the most important are the lipoproteins of the 
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plasma, which function as major transporters of lipids. Lipoproteins are 
classified based on their density to five fractions including high density 
lipoproteins (HDL), low density lipoproteins (LDL), intermediate density 
lipoproteins (IDL), very low density lipoproteins (VLDL) and 
chylomicrones (Davidson and Sittman, 1994). 
Chylomicrones are derived from the intestinal absorption of triglycerides. 
The VLDL is synthesized in the liver for exportation of triglycerides to 
the extra-hepatic tissues; LDL is the final stage in the catabolism of 
VLDL; IDL is a transient lipoprotein formed during the conversion of 
VLDL to LDL, it contains both triglycerides and cholesterol, IDL is 
usually undetectable in normal plasma (Zilva et al., 1994). HDL is 
involved in VLDL and chylomicrones metabolism and also in the 
transport of cholesterol to the liver (Murry et al., 2003).        
1.1.2.1 Low-density lipoprotein (LDL): 
Low-density lipoprotein (LDL) is a lipoprotein that transports 
cholesterol and triglycerides from the liver to peripheral tissues. LDL also 
regulates cholesterol synthesis at these sites. It commonly appears in the 
medical setting as part of a cholesterol blood test, and since high levels of 
LDL-cholesterol can signal medical problems like cardiovascular disease, 
it is sometimes called "bad cholesterol". Each native LDL particle 
contains a single apolipoprotein B-100 molecule (Apo B-100, a protein 
with 4536 amino acid residues) that circulates the fatty acids, keeping 
them soluble in the aqueous environment. In addition, LDL has a highly-
hydrophobic core consisting of polyunsaturated fatty acid known as 
linoleate and about 1500 esterified cholesterol molecules (Segrest, 2001). 
Conditions with elevated concentrations of oxidized LDL particles, 
especially "small dense LDL" (sdLDL) particles, are associated with 
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atheroma formation in the walls of arteries, a condition known as 
atherosclerosis, which is the principal cause of coronary heart disease and 
other forms of cardiovascular disease (Lewington et al., 2007). 
1.1.2.2. High-density lipoprotein (HDL): 
HDL is the smallest of the lipoproteins. It is involved in the 
transport of cholesterol from the peripheral tissues to the liver. They are 
the densest because they contain the highest proportion of protein. They 
contain the A class of apolipoproteins. The liver synthesizes these 
lipoproteins as complexes of apolipoproteins and phospholipids, which 
resemble cholesterol-free flattened spherical lipoprotein particles. They 
are capable of picking up cholesterol, carried internally, from cells they 
interact with. A plasma enzyme called lecithin-cholesterol acyltransferase 
(LCAT) converts the free cholesterol into cholesteryl ester (a more 
hydrophobic form of cholesterol) which is then sequestered into the core 
of the lipoprotein particle eventually making the newly synthesized HDL 
spherical (Kwiterovich, 2000). They increase in size as they circulate 
through the bloodstream and incorporate more cholesterol molecules into 
their structure. High concentrations of functional HDL, which can remove 
cholesterol from cells and atheroma, offer protection against 
atherosclerosis hence termed good cholesterol (Durrington, 2003).   
1.1.3 Triglycerides: 
Triglycerides are fatty acid esters of glycerol, each containing three 
fatty acids. They are transported as lipoproteins from the intestine and the 
liver to various tissues, such as adipose tissue. Following hydrolysis, fatty 
acids are taken up, re-esterified and stored as triglycerides. Plasma 
 6 
 
triglyceride concentrations rise after a fatty meal and remain increased for 
several hours (Stein and Gary, 1994). Triglycerides are absorbed from the 
jejunum and transferred into the intestinal lymph and then to the systemic 
circulation. Liver and intestine are also the major sites of triglycerides 
synthesis. Those formed in the liver, normally being secreted into plasma, 
and those in adipose tissue are either stored locally or reconverted to fatty 
acids and glycerol prior to re-entry into the circulation. They are 
important storage forms of energy (Whitby et al., 1987).    
1.2 Atherosclerosis and coronary heart disease (CHD): 
Atherosclerosis develops from low-density lipoprotein molecules 
(LDL) becoming oxidized (ldl-ox) by free radicals, particularly oxygen 
free radicals. Blood in arteries contains plenty of oxygen and is where 
atherosclerosis develops. Blood in veins contains little oxygen where 
atherosclerosis rarely develops. When oxidized LDL comes in contact 
with an artery wall, a series of reactions occurs to repair the damage to the 
artery wall caused by oxidized LDL. The LDL molecule is globular 
shaped with a hollow core for carrying cholesterol throughout the body 
for making brain tissue, vitamin D, etc. Cholesterol does not dissolve in 
water. Blood is 70% water. The only way cholesterol can move in the 
blood stream is to be carried by LDL. The body's immune system 
responds to the damage to the artery wall caused by oxidized LDL by 
sending specialized white blood cells (macrophages and T-lymphocytes) 
to absorb the oxidized-LDL. Unfortunately, these white blood cells are 
not able to process the oxidized-LDL, and ultimately grow then rupture, 
depositing a greater amount of oxidized cholesterol into the artery wall. 
This triggers more white blood cells, continuing the cycle. Eventually, the 
artery becomes inflamed. The cholesterol plaque causes the muscle cells 
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to enlarge and form a hard cover over the affected area. This hard cover is 
what causes a narrowing of the artery, reduces the blood flow and 
increases blood pressure (Maton et al., 1993) 
Some researchers believe that atherosclerosis may be caused by an 
infection of the vascular smooth muscle cells. Chickens, for example, 
develop atherosclerosis when infected with the Marek's disease 
herpesvirus (Fabricant, 1999). Herpesvirus infection of arterial smooth 
muscle cells has been shown to cause cholesteryl ester (CE) 
accumulation. Cholesteryl ester accumulation is associated with 
atherosclerosis (Hsu et al., 1995). 
Atherosclerosis typically begins in early adolescence, and is usually found 
in most major arteries, yet is asymptomatic and not detected by most 
diagnostic methods during life. The stage immediately prior to actual 
atherosclerosis is known as subclinical atherosclerosis. The majority of 
the process leading to subclinical atherosclerosis can happen without our 
knowing it, especially given the large variety of risk factors (Tuzcu et al., 
2001). Autopsies of healthy young men who died during the Korean and 
Vietnam Wars showed evidence of the disease (Michael and Fishbein, 
2007). It most commonly becomes seriously symptomatic when 
interfering with the coronary circulation supplying the heart or cerebral 
circulation supplying the brain, and is considered the most important 
underlying cause of strokes, heart attacks, various heart diseases including 
congestive heart failure, and most cardiovascular diseases, in general. 
Atheroma in arm, or more often in leg arteries, which produces decreased 
blood flow, is called peripheral artery occlusive disease (PAOD) (Bhatt 
and Topol, 2002). 
Atherogenesis is the developmental process of atheromatous plaques. It is 
characterized by a remodeling of arteries involving the concomitant 
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accumulation of fatty substances called plaques. One recent theory 
suggests that, for unknown reasons, leukocytes, such as monocytes or 
basophils, begin to attack  the endothelium of the artery lumen in cardiac 
muscle. The ensuing inflammation leads to formation of atheromatous 
plaques in the arterial tunica intima, a region of the vessel wall located 
between the endothelium and the tunica media. The bulk of these lesions 
is made of excess fat, collagen, and elastin. At first, as the plaques grow, 
only wall thickening occurs without any narrowing, stenosis of the artery 
opening, called the lumen; stenosis is a late event, which may never occur 
and is often the result of repeated plaque rupture and healing responses, 
not just the atherosclerosis process by itself (Glagov et al., 1987). 
The first step of atherogenesis is the development of fatty streaks, which 
are small subendothelial deposits of oxidized cholesterol and monocyte-
derived macrophages. The exact cause for this process is unknown, and 
fatty streaks may appear and disappear. LDL in blood plasma poses a risk 
for cardiovascular disease when it invades the endothelium and becomes 
oxidized. A complex set of biochemical reactions regulates the oxidation 
of LDL, chiefly stimulated by presence of free radicals in the endothelium 
or blood vessel lining. The initial damage to the blood vessel wall results 
in a "call for help," an inflammatory response. Monocytes (a type of white 
blood cell) enter the artery wall from the bloodstream, with platelets 
adhering to the area of insult. This may be promoted by redox signaling 
induction of factors such as VCAM-1, which recruit circulating 
monocytes. The monocytes differentiate macrophages, which ingest 
oxidized LDL, slowly turning into large "foam cells" – so-described 
because of their changed appearance resulting from the numerous internal 
cytoplasmic vesicles and resulting high lipid content. Under the 
microscope, the lesion now appears as a fatty streak. Foam cells eventually 
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die, and further propagate the inflammatory process. There is also smooth 
muscle proliferation and migration from tunica media to intima responding 
to cytokines secreted by damaged endothelial cells. This would cause the 
formation of a fibrous capsule covering the fatty streak (Maseri and Fuster, 
2003). 
1.2.1 Atherosclerosis and cholesterol consumption:    
According to the lipid hypothesis, abnormally high cholesterol 
levels (hypercholesterolemia), or, more correctly, higher concentrations of 
low density lipoprotein cholesterol (LDL-c) and lower concentrations of 
functional high density lipoprotein cholesterol (HDL-c) are strongly 
associated with cardiovascular disease because these promote atheroma 
development in arteries (atherosclerosis). This disease process leads to 
myocardial infarction (heart attack), stroke and peripheral vascular 
disease. Since higher blood LDL-c, especially higher LDL-c particle 
concentrations and smaller LDL-c particle size, contribute to this process 
more than the cholesterol content of the LDL-c particles (Brunzell, 2008). 
LDL-c particles are often termed "bad cholesterol" because they have 
been linked to atheroma formation. On the other hand, high 
concentrations of functional HDL-c, which can remove cholesterol from 
cells and atheroma, offer protection. These balances are mostly 
genetically determined but can be changed by body build, medications, 
food choices and other factors (Durrington, 2003). 
Individuals with familial hypercholesterolaemia (FH) have very high 
LDL-C and t-C due to LDL-receptor deficiency. One of the main 
arguments for the LDL-receptor hypothesis is that members of such 
families run a great risk of dying from coronary heart disease at an early 
age (Scientific steering committee, 1991). 
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Experiments on the induction of atherosclerosis in animals indicate a wide 
species variation in susceptibility. The rabbit, pig, monkey, and humans 
are species in which atherosclerosis can be induced by feeding cholesterol 
(Murray et al., 2003). 
In 1936, Lande and Sperry noted that the degree of aortic atherosclerosis 
at autopsy of healthy individuals, who had died violently, was 
independent on their blood cholesterol concentration analyzed 
immediately after death (Lande and Sperry, 1936). Their finding was 
similar to results obtained by Mathur and others (Paterson et al., 1960). 
The objection that an analysis of cholesterol after death may not reflect its 
concentration during life was met by Mathur who found that the 
cholesterol concentration was almost constant up to 16 hours after death 
(Cabin and Roberts, 1982). The problem is bypassed by comparing the 
degree of atherosclerosis at death with the individuals’ cholesterol 
measured previously on several occasions. In all these studies, plots of 
blood cholesterol concentrations vs. the lipid content of the aorta or the 
coronary arteries were widely scattered (Shrrett, 1993). 
According to the prevailing paradigm, high LDL cholesterol (LDL-C) is 
said to promote atherosclerosis growth, which explains why it is a risk 
factor for cardiovascular disease. There is much contradictory evidence. It 
is true that high total cholesterol (t-C) is a risk factor for coronary heart 
disease, but mainly in young and middle-aged men. If high t-C or LDL-C 
were the most important cause of cardiovascular disease, it should be a 
risk factor in both sexes, in all populations, and in all age groups. But in 
many populations including women (Jacobs et al., 1992), Canadian and 
Russian men (Dagenais et al., 1990), Maoris (Beaglehole et al., 1980), 
Patients with diabetes (Jarrett, 1992) and patients with the nephrotic 
syndrome (Ravnskov, 1994) the association between t-C and mortality is 
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absent (Jacobs et al., 1992) or inverse (Shestov et al., 1993) or increasing 
t-C is associated with low coronary and total mortality (Anderson et al., 
1987). Most strikingly, in most cohort studies of old people, high LDL-C 
or t-C does not predict coronary heart disease (Lin et al., 2000) or all-
cause mortality (Krumholz et al., 1994) in several of these studies the 
association between t-C and mortality was inverse (Raiha et al., 1997) or 
high t-C was associated with longevity (Jonsson et al., 1997). These 
associations have mostly been considered as a minor aberration from the 
LDL-receptor hypothesis, although by far the highest mortality and the 
greatest part of all cardiovascular disease are seen in old people (Abbott et 
al., 2002). 
More recent autopsy studies have found weak or inconsistent correlations 
between LDL-cholesterol or total cholesterol and various measures of 
atherosclerosis (Sharrett, 1993). For instance, the most severe degree of 
atherosclerosis was found mainly in individuals with extremely high 
cholesterol, whereas small differences were seen in the rest (Solberg et 
al., 1985). A correlation was found in White men, but not in Black men 
(Oalmann et al., 1981) in men but not in women (Feinleib et al., 1979) in 
individuals below, but not above age 80 years (Sadoshima et al., 1980) 
and in the coronary arteries, but not in the thoracic or abdominal aorta 
(Reed et al., 1989).  
The weak and unpredictable correlations probably reflect bias, because 
most of the studies were performed on selected individuals. In such large 
projects, the main object of which was to study risk factors for 
cardiovascular disease, individuals with such diseases, or with high 
cholesterol, were preferred for post-mortem examination (Sorlie et al., 
1981) which means that the proportion of individuals with familial 
hypercholesterolaemia must have been much larger than in the general 
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population. As such patients have very high cholesterol and are more 
prone to vascular changes, their inclusion automatically creates a 
correlation between degree of atherosclerosis and LDL or total cholesterol 
(Solberg et al., 1977). It is questionable if the vascular changes seen in 
familial hypercholesterolaemia are synonymous with atherosclerosis 
(Stehbens and Martin, 1991). Therefore, to prove that the concentration of 
LDL-cholesterol has importance in the general population, it is necessary 
to exclude individuals with familial hypercholesterolaemia (Stehbens, 
2001).  
The lack of an association in these studies may be explained by an 
influence of other important risk factors. A more reliable parameter is 
exposure-response. If the amount of circulating cholesterol has any 
importance, sequential changes of its concentrations should be followed 
by parallel changes of atherosclerosis growth (Hecht and Superko, 2001).  
In a few observational studies with coronary angiography, the correlation 
of this parameter, graded as continuous variables, was analyzed. In three 
studies, no correlation was found (Bruschke et al., 1989) in two others; 
progression of atherosclerosis was associated with a decrease in 
cholesterol, not an increase (Shub et al., 1981).  
In many trials exposure response was analyzed, several explanations were 
offered: most commonly that other lipids or lipid combinations explained 
the findings. However, high-density lipoprotein (HDL) cholesterol was 
analyzed in twelve studies (Niebauer et al., 1996) triglycerides in ten 
(Sacks et al., 1994) apo-lipoprotein B in six (Blankenhorn et al., 1990) 
apo-lipoprotein A1 in three (Sutherland et al., 1998) very-low-density-
lipoprotein cholesterol in three and small, dense LDL-cholesterol in one 
study but none of them were associated with atherosclerosis growth 
(Ruotolo et al., 1998). In an early trial using visual evaluation of the 
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angiographic findings (Krauss et al., 1987) intermediate-density 
lipoprotein cholesterol was associated with atherosclerotic progression, 
but in two others using computer-assisted analysis (Sutherland et al., 
1998) no association was found. In three trials, the ratio total 
cholesterol/HDL cholesterol was inversely associated with atherosclerotic 
progression (Niebauer et al., 1996) but in one it was seen only in the 
placebo group,41 and in another the analysis was not corrected for other 
risk factors (Quinn et al., 1994). 
1.2.2 Atherosclerosis and saturated fats consumption: 
Fat that occurs naturally in living matter contains varying 
proportions of saturated and unsaturated fat. Foods that contain a high 
proportion of saturated fat are dairy products (especially cream and cheese 
but also butter and ghee), animal fats such as suet, tallow, lard and fatty 
meat, coconut oil, cottonseed oil, palm kernel oil and chocolate, and some 
prepared foods (U.S Department of Agriculture, 2007). 
There are several kinds of naturally occurring saturated fatty acids, their 
only difference being the number of carbon atoms - from 1 to 24. 
Saturated fatty acids have no double bonds between the carbon atoms of 
the fatty acid chain; hence, they are fully saturated with hydrogen atoms. 
While nutrition labels usually lump them together, the saturated fatty 
acids appear in different proportions among food groups. Lauric and 
myristic acids are most commonly found in "tropical" oils (e.g. palm 
kernel, coconut) and dairy products. The saturated fat in meat, eggs, 
chocolate and nuts is primarily palmitic and stearic acid (Beegom and 
Singh, 1997). 
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Table (1) Some common examples of saturated fatty acids: 
 
Food Lauric acid Myristic acid Palmitic acid Stearic acid
Coconut oil 47% 18% 9% 3% 
Butter 3% 11% 29% 13% 
Ground beef 0% 4% 26% 15% 
Dark 
chocolate 
0% 0% 34% 43% 
Salmon 0% 1% 29% 3% 
Eggs 0% 0% 27% 10% 
Cashews 2% 1% 10% 7% 
Soybean oil 0% 0% 11% 4% 
 
? Lauric acid with 12 carbon atoms (contained in coconut oil, palm 
oil and breast milk, 
? Myristic acid with 14 carbon atoms (contained in cow milk and 
dairy products), 
? Palmitic acid with 16 carbon atoms (contained in palm oil, hence 
the name, and meat), 
? Stearic acid with 18 carbon atoms (also contained in meat and 
cocoa butter).  
Harvard Nurses' Health Study found that diets lower in 
carbohydrate and higher in protein and animal fat are associated with a 
statistically insignificant decrease in risk of coronary heart disease in 
women. When vegetable sources of fat and protein are chosen, these diets 
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may moderately reduce the risk of coronary heart disease (Halton et al., 
2006). 
Diets high in saturated fat are correlated with an increased incidence of 
atherosclerosis and coronary heart disease according to a number of 
studies, both in African green monkeys (Wolfe et al., 1994) and humans, 
such as a study of infant diets (Lapinleimu et al., 1995)  
hypercholesterolemic men (Francisco et al., 2001). Some studies have 
suggested that diets high in saturated fat increase the risk of heart disease 
and stroke. Epidemiological studies have found that those whose diets are 
high in saturated fatty acids, including lauric, myristic, palmitic, and 
stearic acid, had a higher prevalence of coronary heart disease (Kromhout 
et al., 1995). Additionally, controlled experimental studies have found 
that people consuming high saturated fat diets experience negative 
cholesterol profile changes (Mendis et al., 2001). A 2003 meta-analysis 
published in the American Journal of Clinical Nutrition concluded that 
diets high in saturated fat negatively affected cholesterol profiles — 
predictors of a heart attack and other cardiovascular diseases (U.S. 
Department of Health and Human Services, 2005). 
Experiments in which subjects were randomly assigned to either a control 
or Mediterranean diet (which replaces saturated fat with mono and 
polyunsaturated fat) showed that subjects assigned to a Mediterranean diet 
exhibited a significantly decreased likelihood of suffering a second heart 
attack, cardiac death, heart failure or stroke (Lorgeril et al., 1999). 
Epidemiological studies of heart disease have implicated the four major 
saturated fatty acids to varying degrees. The World Health Organization 
has determined that there is "convincing" evidence that myristic and 
palmitic acid intake increases the probability, "possible" risk from lauric 
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acid, and no increased risk at all from stearic acid consumption (World 
Health Organization). 
A 2004 statement released by the Centers for Disease Control (CDC) 
determined that "Americans need to continue working to reduce saturated 
fat intake. Additionally, reviews by the American Heart Association led 
the Association to recommend reducing saturated fat intake to less than 
7% of total calories according to its 2006 recommendations (Lichtenstein 
et al., 2006). This concurs with similar conclusions made by the World 
Health Organization (WHO) and the US Department of Health and 
Human Services, both of which determined that reduction in saturated fat 
consumption would positively affect health and reduce the prevalence of 
heart disease (U.S. Department of Health and Human Services, 2005).  
The World Health Organization (WHO) has concluded that saturated fats 
negatively affect cholesterol profiles, predisposing individuals to heart 
disease, and recommends avoiding saturated fats in order to reduce the 
risk of a cardiovascular disease (WHO). 
Another confounding issue may be the formation of exogenous (outside 
the body) advanced glycation end products (AGEs) and oxidation 
products generated during cooking, which it appears some of the studies 
have not controlled for. It has been suggested that, "given the prominence 
of this type of food in the human diet, the deleterious effects of high-
(saturated)fat foods may be in part due to the high content in glycotoxins, 
above and beyond those due to oxidized fatty acid derivatives. The 
glycotoxins, as he called them, are more commonly called AGEs 
(Koschinsky et al., 1997). 
In a study of 235 postmenopausal women, the study subjects established 
coronary artery disease. Most were hypertensive and many had diabetes 
(19–31%). Their body mass index ranged from 29 to 30 and their lipid 
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profile indicated combined hyperlipidemia. These combined 
characteristics are consistent with metabolic syndrome. Coronary 
angiography was employed to examine 2,243 coronary artery segments; 
once at the start of the study and once more at its conclusion. The study 
concluded that "in postmenopausal women with relatively low total fat 
intake, a greater saturated fat intake is associated with less progression of 
coronary atherosclerosis." The same study revealed similarly surprising 
results when it was disclosed that a greater consumption of 
polyunsaturated oils "was also associated with greater progression of 
atherosclerosis (Mozaffarian et al., 2004) (Knopp and Retzlaff, 2004). 
A study of 297 acute myocardial infarction (MI) cases in Portuguese 
males, published in February 2007, concluded that, "Total fat intake, 
lauric acid, palmitic acid, and oleic acid were inversely associated with 
acute MI" and that, "Low intake of total fat and lauric acid from dairy 
products was related to acute MI". The researchers also stated, in 
revealing the results of this study that some prospective studies show that 
replacing saturated fat with unsaturated fat is more effective in lowering 
CHD risk than reducing total fat consumption (Carla Lopes et al., 2007). 
Fulani of northern Nigeria get around 25% of energy from saturated fat, 
yet their lipid profile is indicative of a low risk of cardiovascular disease. 
This finding is likely due to their high activity level and their low total 
energy intake (Glew et al., 2001). 
A 2004 article in The American Journal of Clinical Nutrition raised the 
possibility that the supposed causal relationship between saturated fats 
and heart disease may actually be a statistical mistake because of the 
greater precision with which saturated fats have been measured (Journal 
of Clinical Nutrition, 2004). 
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1.3 Histopathology of atherosclerosis 
 
Cholesterol enrichment of arteries may induce biochemical and 
structural abnormalities in vascular smooth muscle resulting in increased 
arterial contractile sensitivity. We studied the effects of a high-cholesterol 
diet on arterial structural properties and vascular reactivity in young 
rabbits. In vivo measurements of aortic intimal-plus-medial thickness 
using high resolution ultrasound imaging were obtained before and after 3 
weeks of a high-cholesterol diet in 12 rabbits (group 2) and compared to 
data from 12 animals a cholesterol-free diet fed (group 1). Six rabbits 
(group 3) were studied before and after a 3-week, high-cholesterol diet 
and after a subsequent 13-week, cholesterol-free recovery diet. In groups 
2 and 3, high dietary cholesterol caused an increase in intimal-plus-medial 
thickness from 0.31 mm and 0.33 mm to 0.88 mm and 0.89 mm, 
respectively. (Ludwig et al., 1991). 
Heart sections of rats fed saturated medium chain triglycerides, when 
stained with Light Green SF Yellowish revealed areas of muscle fibrils 
that did not accept the stain, probably as a consequence of cellular 
damage. (Hans and Ruth, 1973)  
The liver plays an important role at the cholesterol metabolism in S. 
Dawley rats (Dietschy et al., 1993). Hepatic fibrosis was reported to be 
induced by Cholesterol supplemented diet (Hausner et al., 1995). It has 
been shown that it causes Cholesterol accumulation in cells by high 
Cholesterol diet (Higley and Taylor, 1984). Most forms of chronic liver 
disease are associated with the development of the fibrosis (Britton and 
Bacon, 1994). It has been stated that, the stimulation of non parenchyma 
cells, i.e., myofibroblasts, could participate in the mechanism of the 
hepatic fibrosis (Friedman, 1993). 
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A computed diet based on cereals and spices incorporated with saturated 
fats fed to albino rats, histopathological examination of liver tissue in 
particular showed mild cytoplasmic vacuolation (Ramachandran et al., 
2006). When male rats fed saturated medium chain triglycerides, many 
livers revealed marked proliferation of bile ducts (Hans and Ruth, 1973). 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1. Experimental details 
These experiments were designed to investigate the effect of 
feeding high levels of cholesterol or saturated fats on formation of 
atherosclerotic plaques in Wistar albino rats. 
2.1.1. Experimental animals 
Thirty Wistar albino rats obtained from the University of Khartoum 
and National Center for Research, Khartoum were used in this study. The 
rats were housed identically in stainless steel cages in an air room under 
suitable conditions. All of the rats were initially fed a standard laboratory 
diet for 15 days to acclimatize to the laboratory. Tap water was freely 
available.  
2.1.2. The experimental diet 
The rats were divided into three groups and given a basal diet 
which fulfilled their requirement. The composition of the basal diet for all 
groups according to NRC (National Research Council, 1996)  was as 
follows: 
Group "A" (the control) received the basal diet. Each kg contains  
Wheat flour              692g 
Dry meat                  165g 
Sodium chloride       3g 
Oil                               140g 
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Group "B" (cholesterol treated) received cholesterol powder 
supplemented to the basal diet of the rats, according to (Sharma, 1984). 
Each kg contains 
Wheat flour              672g 
Dry meat                  165g 
Sodium chloride       3g 
Oil                               140g 
Cholesterol                 20g 
 
Group "C" (saturated fats treated) received 14 % cow tallow 
supplemented to the basal diet of the rats. Each kg contains 
Wheat flour              692g 
Dry meat                  165g 
Sodium chloride       3g 
 Saturated fats            140g 
2.2. Equipment used during the study 
? Heparinized capillary tubes were obtained from Umedic 
Company. 
? Heparinized blood containers were obtained from Umedic 
Company. 
? Plane blood containers were obtained from plastilab. 
? Centrifuge. 
? Automatic pipettes. 
? Colorimeter. 
2.2.1. Chemicals 
? Cholesterol powder was obtained from Himedia Company. 
 22 
 
2.3. Experimental procedure 
The animals were divided into three groups of ten animals each. 
These groups were named as A, B, and C. Group A was given the basal 
diet and served as control, group B received 2% cholesterol added to the 
basal diet. Group C received 14% saturated fats. Blood samples were 
collected after one, two and three months following treatment for the 
determination of the levels of the cholesterol and its fractions and the 
triacylglycerols. All animals were sacrified by the end of the experiment 
and heart and liver samples were collected for histopathology. 
2.3.1. Blood sampling 
One and half milliliter of blood was collected from the rats orbital 
plexus after an overnight fast by capillary tubes and was put in 
heparinized containers; the blood was centrifuged at 5000 rpm for 10 
minutes. Then the plasma was placed into plane containers and used 
immediately. 
2.4. Analytical methods 
2.4.1. Colorimetric analysis 
All cholesterol fractions and triacylglycerols were estimated 
using the colorimeter.  
2.4.2. Total cholesterol estimation 
Principle of the method was carried according to (Richmond, 
(1973) 
In the presence of cholesterol esterase, the cholesterol esters in 
the sample are hydrolyzed to cholesterol and free fatty acids. The 
cholesterol produced is oxidized by cholesterol oxidase to 
Quinoneimine and hydrogen peroxide. Hydrogen peroxide is detected 
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Cholesterol esterase 
cholesterol oxidase 
cholesterol oxidase 
by chromogenic oxygen acceptor, phenol – ampyrone, in the presence 
of peroxidase. The red quinine formed is proportional to the amount of 
cholesterol present in the sample. 
   
Cholesterol ester + H2O     Cholesterol + Fatty acid 
 
Cholesterol + ½ O2 + H2O       Cholestenone+ H2O2 
 
2H2 O2 + 4 –Aminoantipyrine + Phenol   
 Quinoneimine+4H2 O 
Contents and composition of reagents  
Reagent (1)   buffer pH 6.9                                 90 mmol/L 
                    Phenol                                              26 mmol/L 
Reagent (2) Cholesterol esterase (CHO)              300 U/L 
                     Cholesterol oxidase (CHOD)           300 U/L 
                     Phenol- ampyrone/ peroxidase       1250 U/L 
                     4 – Aminoantipyrine                      0.4 mmol/L  
 Cholesterol Standard                                           200 mg/dl.  
 Procedure: 
1- The working reagent was prepared by dissolving one vial of 
Reagent (2) in one bottle of Reagent (1). 
2-  The working reagent was brought to room temperature. 
3- Into labeled test tubes the following were pipette: 
 Blank Standard Sample 
Cholesterol standard      ___                10 µl      ___    
Sample      ___      ___       10 µl 
Working reagent      1.0 ml       1.0 ml        1.0 ml 
 
 24 
 
4- The tubes were incubated for 10 minutes at room temperature 
(37º C). 
5- The absorbance of both standard and samples were measured at 
500 nm against the blank. 
   
Calculations: 
 The cholesterol concentration in the samples was calculated by the 
following general formula:  
Cholesterol concentration (mg/dl) = Absorbance of sample  ×200 
                                                   Absorbance of standard   
2.4.3. Low density lipoprotein-cholesterol (LDL-C) estimation 
Principle of the method was carried according to (Assmann et al ., 
1984) 
LDL-c particles in the sample are precipitated with polyvinyl 
sulphate. Their concentration is calculated from the difference between 
the serum total cholesterol and the cholesterol in the supernatant after 
centrifugation. The cholesterol is spectrophometrically measured by 
means of the coupled reactions as described for cholesterol in page 19.  
Contents and composition of reagents 
1- Reagent (1): polyvinyl sulphate 3g/L, polyethylene glycol 3g/L. 
2- Biosystem cholesterol kits (cod. 11805, 11505,11506, 11539).   
Procedure: 
1- Into labeled test tubes the following were pipette: 
 
Sample 
 
0.4 ml 
 
Reagent B 
 
0.2 ml 
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2- The tubes were let to stand for 10 minutes  at room temperature. 
3- The tubes were centrifuged at 4000 r.p.m for 15 minutes. 
4- The supernatant was collected carefully. 
5- The cholesterol kit was brought to room temperature. 
6-  Into labeled test tubes the following were pipette : 
 Blank Standard Sample 
Distilled water    20 µl      ___    ___ 
Cholesterol standard      ___      20 µl    ___ 
Sample supernatant      ___       ___     20 µl 
Cholesterol reagent       1.0 ml         1.0 ml      1.0 ml
 
7- The tubes were mixed and incubated at room temperature for 30 
minutes. 
8- The  absorbance of both sample and standard were measured at 500 
nm against the blank. 
Calculations: 
Since the dilution factor of the sample in the precipitation is 1.5 the 
concentration of cholesterol was calculated as follow: 
Cholesterol in the supernatant(mg/dl)= Absorbance of sample  
×200×1.5      Absorbance of standard    
                                                                  
2.4.4. High density lipoprotein-cholesterol (HDL-C) estimation: 
Principle of method was carried according to (Bachorik, 1997) 
Very low density lipoproteins (VLDL) and low density 
lipoproteins (LDL) in the sample are precipitated with phosphotungstate 
and magnesium ions. The supernatant contains HDL-c. The HDL-c is then 
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spectrophotometrically measured by means of coupled reactions described 
for total cholesterol in page 19.  
Contents and composition of reagents 
1- Reagent (B): 50 ml, contains phosphotungstate (0.4 m 
mol/L) and magnesium chloride (20 m mol/L). 
2- HDL-c standard concentration = 40 mg/dl. 
3- Reagent (A)-Biosystem cholesterol kits (cod. 11805, 
11505,11506, 11539).   
Procedure: 
1- Into labeled centrifuge tubes the following were pipette: 
Sample 0.2 ml 
Reagent B 0.5 ml 
2- The tubes were let to stand for 10 minute at room temperature. 
3-  The tubes were centrifuged at 4000 r.p.m for 10minutes. 
4- The supernatant were collected carefully. 
5- The cholesterol reagent brought to room temperature. 
6- Into labeled test tubes the following were pipette: 
 Blank Standard Sample 
Distilled water     100 µl       ___     ___ 
HDL –cholesterol standard     ___     100 µl     ___ 
Sample supernatant     ___     ___     1oo µl 
Reagent (A)(cholesterol
kit) 
    1.0 ml     1.0 ml     1.0 ml 
 
7- The tubes were incubated for 10 minutes at 37ºC. 
8- The absorbance of  both sample and standard were measured at 500 nm 
against the blank. 
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Calculations: 
The HDL cholesterol concentration in the samples was 
calculated by the following general formula:  
Concentration of HDL cholesterol - (mg/dl) = Absorbance of sample  
×40×3.5 
                                                              Absorbance of standard 
   
2.4.5. Very Low Density Lipoproteins-cholesterol (VLDL-C) 
calculation according to Friedewald, (1972) 
According to the Friedewald calculation, VLDL cholesterol is 
calculated as triglycerides divided by a factor of 5 when lipids are 
measured in milligrams per deciliter and by a factor of 2.22 when 
measured in millimoles per liter. The triglycerides/5 ratio as a proxy for 
VLDL cholesterol is based on the observation that the ratio of the mass of 
triglycerides to that of cholesterol in VLDL is relatively constant, 
approximately 5:1 in healthy individuals. However, this means of 
estimating VLDL cholesterol introduces the well-known limitations of the 
Friedewald equation. The triglyceride/cholesterol ratio in VLDL will be 
greater than 5:1 at triglyceride concentrations more than 400 mg/dl and 
the VLDL cholesterol concentration will consequently be overestimated. 
Since triglyceride concentrations in this experiment were less than 400 
mg/dl, VLDL cholesterol was calculated as triglycerides divided by a 
factor of 5. 
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Lipase  
Glycerol Kinase
G3P-oxidase  
Peroxidase 
2.4.6. Triglycerides estimation 
Principle of the method was according to (Cole et al., 1997) 
Triglycerides in the sample originate, by means of coupled 
reactions described below, a colored complex that can be measured by 
spectrophotometery. 
Triglyceride + H2O    Glycerol + fatty acids. 
 
Glycerol + 3ATP      Glycerol-3-P + 3ADP. 
 
Glycerol-3-P + O2     Dihydroxyacetone-P +H2O. 
 
2H2O+4-Aminoantipyrine+4-Chlorophenol  
 Quinoneimine +4H2O. 
 
Contents and composition of reagents 
1- Reagent (A) contains: 
                        Buffer     45 mmol/L 
                          Chlorophenol    6 mmol/L  
                          Magnesium chloride   5 mmol/L 
                          Lipase      >100 u/ ml 
                          Glycerol kinase    >1.5 u/ml 
                          Glycerol -3- oxidase phosphate  >4 u/ ml 
                                  Peroxidase     >0.8 u/ml                                       
                                  4- aminoantipyrine   0.75 mmol/L 
                          ATP     0.9 mmol/L 
                           PH     7.0 
2- Triglycerides Standard: Glycerol equivalent to 200 mg/dl triolein.   
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Procedure: 
1- Reagents were brought to room temperature. 
2- Into labeled test tubes the following were pipette: 
 
 
  Sample Standard Blank 
Sample     10 ml     ___     ___ 
Triglyceride standard     ___     10 ml     ___ 
Reagent     1.0 ml     1.0 ml     1.0 ml 
 
3- The tubes were incubated for 15 minutes at room temperature. 
4- The absorbance of both sample and standard were measured at 
500 nm against the blank.      
Calculations: 
The triglycerides concentration in the samples was calculated by 
the following general formula:  
Concentration of triglyceride (mg/dl) = Absorbance of sample  ×200 
                                                   Absorbance of standard  
    2.5 Histopathological diagnosis according to (Drury and 
Wallington, 1980) 
    2.5.1 Collection of samples 
Heart and liver samples were collected immediately after 
scarifying the rats and put in a fixative solution before any of the post 
mortem changes take place. 
     2.5.2 Fixation  
Fixation is the preservation of cells and tissues constituents as 
life-like manner as possible. The aim of fixation is to stop autolysis 
(intracellular enzyme reaction) and stop bacterial decomposition. The 
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volume of the fixative is ten times to that of sample. 10% neutral formalin 
was used as fixative agent. Neutral formalin prepared as follow: 
Formalin     = 100 ml 
Distilled water    =  900 ml 
Disodium hydrogen orthophosphate =   6.5 gm 
Sodium dihydrogen  orthophosphate =   4.0 gm 
 
     2.5.3 Dehydration and clearing 
Dehydration means removal of water from tissues. First the 
tissues were cut {trimmed} into small squire pieces about one cubic 
centimeter and labeled with a pencil then washed in running tap water for 
15 minutes to remove the fixing agent. 
The following different concentrations of alcohol were used to remove 
water from tissues: 
Sections were put in 50% alcohol, 60% alcohol, 70% alcohol, 80% 
alcohol, 90% alcohol, 95% alcohol and 100% alcohol (absolute alcohol). 
Clearing is to make the sections transparent so it can be examined 
microscopically. Chloroform and zylene were used as clearing agents. 
      2.5.4 Impregnation, blocking and section cutting 
Melted paraffin wax was used to remove the clearing agent from 
the tissues and penetrate the tissues to fill the intracellular space to 
facilitate cutting. Then sections were cut with aid of rotary microtome into 
5—6 microns (one layer thickness). 
2.5.5 Staining 
Before staining process sections were treated as follow: 
1- Zylene was used to remove wax from the sections (10 minutes). 
2- Absolute alcohol was used to remove zylene (two changes 5 minutes 
each). 
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3- The sections are then hydrated [return water to sections] as follow: 
Rinse in 90% alcohol for 5 minutes, 70% alcohol for 5 minutes 
and distilled water for 5 minutes.  
  2.5.5.1 Preparation of stains  
A- Haematoxyline: 
Haematoxyline powder = 2 gm 
Absolute alcohol  = 100 ml 
Glycerin   = 100 ml 
Distilled water  = 100 ml 
Glacial acetic acid = 100 ml 
Ammonium  = 14 gm 
  B- Eosin (1%): 
1 gm of eosin powder dissolved in 100 ml of distilled water. 
  C- Acid alcohol (1%): 
  1 ml of concentrated HCL and 99 ml of 70% alcohol mixed 
together.                                       
      2.5.5.1.1 Staining procedure 
        1- Sections were stained in haemoxyline for 10 minutes. 
2- Sections then washed in running tap water for several times. 
3- Then differentiated in 1% acid alcohol. 
4- Sections rinsed in running tap water for at least 10 minutes. 
5- Counter stain with eosin 2-3 minutes. 
6- Then rinsed quickly in tap water. 
7- The sections were then dehydrated in70%, 90% and absolute 
alcohol. 
8- After removal of excess alcohol sections were cleared in zylene. 
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2.5.6 Mounting 
The sections was covered with a cover glass (cover slip) 
using a suitable mounting medium (Canada balsam). Sections 
were ready to examine microscopically after overnight drying at 
room temperature.  
 2.6. Statistical analysis 
Results were analyzed using SPSS version 11. The significance 
was determined at 5% level by using the t-test. 
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CHAPTER THREE 
RESULTS 
3.1 The effect of feeding high cholesterol diet or high saturated fats 
diet on blood cholesterol level in rats 
 
3.1.1 Total cholesterol (TC) 
The effect of feeding high saturated fats or high cholesterol diet 
to albino rats during three months on total cholesterol (TC) is represented 
in table (2) and figure (1). 
After the first month the level of the total cholesterol showed similar 
levels in the group fed high saturated fats diet (group C) and the control 
(group A),but the group fed high cholesterol diet (group B) presented 
significantly (P < 0.05) higher total cholesterol level compared to other 
groups. 
This effect was continued throughout the experimental period but with 
increasing values, except in group B which showed lower level after the 
second month compared to the level after one month. but after three 
months it scored very high level compared to other groups and it was 
highly significant (P < 0.05). 
After three months the level of total cholesterol in all groups showed 
higher levels compared to the level after one month, and it scored very 
highly significant (P < 0.05) level in group B compared to the control 
group and to the level after one month in the same group. The difference 
between the level of cholesterol after one month and after three months in 
this group was also highly significant (P < 0.05).  
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Table (2) 
Cholesterol level after supplementation of 2% cholesterol (group B) 
and 14% saturated fats (group C) compared to control (groupA) 
 Total cholesterol (mg/dl) 
                            Months 
Groups 
            1         2                      3 
Group A (control) 107 .5 ±4.42 a A 129.35±12.77 a A    135.14±10.83 a B*
Group B (high cholesterol) 327.5±43.29 b A 270.31±10.28 b A    557.31±43.89 b
B*** 
Group C (high saturated 
fats) 
111.25±6.02 a A 135.14±10.83 a A     155.00±13.46a B*
 
Means ± SE within the same column having different superscript 
small letters are significantly different at (P < 0.05). 
Means ± SE within the same row having different superscript 
capital letters are significantly different at (P < 0.05). 
 
(P < 0.05)*   Significant 
(P < 0.01)** Highly significantly 
(P < 0.001)*** Very highly significantly 
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Fig. (1) 
 The level of cumulative value of total cholesterol in group (B) and 
group (C) compared to group (A) after supplementation of 2% 
cholesterol powder and 14% saturated fatty acid mixed with the 
basal diet respectively 
 
• Bars having different superscript small letters are 
significantly different at (P < 0.05) based on t- test. 
3.1.2 LDL-cholesterol (LDL-C) 
The effect of feeding high saturated fats or high cholesterol diet 
to albino rats for three months on LDL-cholesterol (LDL-C) is 
represented in table (3) and figure (2). 
After the first month the level of the LDL-cholesterol showed similar 
levels in the group fed high saturated fats diet (group C) and the control 
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(group A),but the group fed high cholesterol diet (group B) presented 
significantly at (P < 0.05) higher LDL-C level compared to other groups. 
This effect showed similar results throughout the next two months with 
increasing LDL-C values, except in both group A and group C which 
showed lower levels after the third month compared to the levels after the 
second month. 
After second and third month LDL-C level in group A and group C 
showed significantly (P < 0.01) higher LDL-C compared to LDL-C level 
after one month but after three months LDL-C level in group B scored 
very high level compared to such group and other groups and it was 
highly significant (P < 0.01). 
 
Table (3) 
Cumulative value of LDL-c level after supplementation of 2% 
cholesterol (group B) and 14% saturated fats (group C) compared to 
control (group A): 
 LDL-C  (mg/dl) 
                            Months 
Groups 
1 2 3 
Group A (control) 61.13±3.44  a A 93.10±8.18 a B** 69.17±8.72 a B* 
Group B (high cholesterol) 240.67±32.93 b A 244.25±19.21 b A 453.64±14.51 b 
B** 
Group C (high saturated 
fats) 
66.56±7.55 a A 100.80±8.87 a B** 93.67±14.77 a B**
 
Means ± SE within the same column having different superscript 
small letters are significantly different at (P < 0.05) based on t- test. 
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Means ± SE within the same row having different superscript capital 
letters are significantly different at (P < 0.05). 
(P < 0.05)*   Significant 
(P < 0.01)** Highly significantly 
(P < 0.001)*** Very highly significantly 
 
 
 
  
Fig. (2) 
 The level of cumulative value of LDL-C in group (B) and group 
(C) compared to group (A) after supplementation of 2% cholesterol 
powder and 14% saturated fatty acid mixed with the basal diet 
respectively 
 
• Bars having different superscript small letters are 
significantly different at (P < 0.05) based on t- test. 
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3.1.3 HDL- cholesterol (HDL-C) 
The effect of feeding high saturated fats or high cholesterol diet 
to albino rats for three months on HDL-cholesterol (HDL-C) is 
represented in table (4) and figure (3). 
After the first month from starting the experiment the level of HDL-
cholesterol (HDL-C)  showed significantly high level at (P < 0.05) in the 
group fed high cholesterol diet (group B) compared to the control group, 
while HDL-C levels in the group fed high saturated fats diet (group C) 
and the control (group A) were  showed  similar results. 
This effect was continued throughout the experimental period showed 
similar results but with decreasing HDL-C values in the second month. 
After the third month the levels increased compared to the level after one 
month and it scored very highly significant (P < 0.001) level in group B.  
 
Table (4) 
HDL-C level after supplementation of 2% cholesterol (group B) and 
14% saturated fats (group C) compared to control (group A) 
   HDL-C (mg/dl) 
                            Months 
Groups 
1 2 3 
Group A (control) 41.36±4.81a 
A 
29.05±1.89 a
B** 
53.39±7.07 a A 
Group B (high cholesterol) 64.10±4.35 b
A 
20.36±1.11 b 
B** 
90.69±12.91b B**
Group C (high saturated 
fats) 
43.71±4.85 a
A 
33.34±2.04 a A 52.71±5.40 a A   
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Means ± SE within the same column having different superscript 
small letters are significantly different at (P < 0.05) based on t- test. 
 
Means ± SE within the same row having different superscript capital 
letters are significantly different at (P < 0.05). 
(P < 0.05)*   Significant 
(P < 0.01)** Highly significantly 
(P < 0.001)*** Very highly significantly 
 
 
 
Fig. (3) 
 The level of cumulative value of HDL-C in group (B) and group 
(C) compared to group (A) after supplementation of 2% cholesterol 
powder and 14% saturated fatty acid mixed with the basal diet 
respectively 
 
• Bars having different superscript small letters are 
significantly different at (P < 0.05) based on t- test. 
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3.1.4 VLDL-cholesterol (VLDL-C) 
The effect of feeding high saturated fats or high cholesterol diet 
to albino rats for three months on VLDL-cholesterol (VLDL-C) is 
represented in table (5) and figure (4).  
After the first month from starting the experiment the level of VLDL-
cholesterol (VLDL-C)  showed significantly lower level (P < 0.05) in the 
group fed high cholesterol diet (group B) compared to the other groups, 
while VLDL-C levels in the group fed high saturated fats diet (group C) 
and the control (group A) showed  similar results. 
This effect was continued for the second month but with small decreasing 
VLDL-C values in group A and B. After the third month very 
significantly (P < 0.001) high level were scored in all groups compared to 
levels after the first month. 
 
Table (5) 
VLDL-C level after supplementation of 2% cholesterol (group B) and 
14% saturated fats (group C) compared to control (group A) 
 VLDL-C  (mg/dl) 
                            Months 
Groups 
1 2 3 
Group A (control) 16.63 ± 1.70 a A  14.47±2.33 a 
A 
29.47±2.10 a 
B***  
Group B (high cholesterol)  8.00±1.03 b A 6.31±0.89 b B*  27.36±2.32 a 
B*** 
Group C (high saturated fats)  15.16±1.53 a A  16.63±3.47 a 
A 
33.89±1.92 a 
B*** 
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Means ± SE within the same column having different superscript 
small letters are significantly different at (P < 0.05) based on t- test. 
 
Means ± SE within the same row having different superscript capital 
letters are significantly different at (P < 0.05). 
 
(P < 0.05)   Significant 
(P < 0.01)  Highly significantly 
(P < 0.001)  Very highly significantly 
 
 
Fig. (4) 
 The level of cumulative value of VLDL-C in group (B) and group 
(C) compared to group (A) after supplementation of 2% cholesterol 
powder and 14% saturated fatty acid mixed with the basal diet 
respectively 
• Bars having different superscript small letters are 
significantly different at (P < 0.05) based on t- test. 
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3.2 The effect of feeding high cholesterol diet or high saturated fats 
diet on blood triacyleglycerol level in rats 
3.2 Triacylgleycerol (TAG) 
The effect of feeding high saturated fats or high cholesterol diet 
to albino rats for three months on triacyleglycerol (TAG) is represented in 
table (6) and figure (5). 
After the first month from starting the experiment the level of TAG  
showed significantly lower level (P < 0.05) in the group fed high 
cholesterol diet (group B) compared to the control group, while TAG 
levels in the group fed high saturated fats diet (group C) and the control 
(group A) showed  similar results. 
This effect continued for the second month but with small increasing 
TAG values in group C. After the third month very significantly (P < 
0.001) high levels were scored in all groups compared to levels after the 
first month. 
Table (6) 
TAG level after supplementation of 2% cholesterol (group B) and 
14% saturated fats (group C) compared to control (group A) 
 TAG(mg/dl) 
                            Months 
Groups 
1 2 3 
Group A (control) 83.16±8.52 a A 73.69±11.64 a A 149.47±10.02 a B**
Group B (high cholesterol) 40.00±5.16 b A 44.08±11.77 b B* 136.72±11.63 a 
B*** 
Group C (high saturated 
fats) 
75.79±7.66 a A 83.16±17.36 a A 169.47±6.60 a B***
 
 43 
 
Means ± SE within the same column having different superscript 
small letters are significantly different at (P < 0.05) based on t- test. 
 
Means ± SE within the same row having different superscript capital 
letters are significantly different at (P < 0.05). 
 
(P < 0.05)*   Significant 
(P < 0.01)** Highly significantly 
(P < 0.001)*** Very highly significantly 
 
 
Fig. (5) 
 The level of cumulative value of TAG in group (B) and group (C) 
compared to group (A) after supplementation of 2% cholesterol 
powder and 14% saturated fatty acid mixed with the basal diet 
respectively 
• Bars having different superscript small letters are 
significantly different at (P < 0.05) based on t- test. 
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3.3 Histopathological Findings 
 
In group (B) which treated with 2% cholesterol for three months 
the heart showed edema of the cardiac muscles (fig.6) and zenker 
necrosis, hyalinization and there was increased thickness of the blood 
vessels (fig.7) and presence of cholesterol cleft (fig.8). 
The liver in group (B) showed vacuolization (fig.9), dilatation of sinusoid, 
necrosis and disorganization of hepatocytes (fig.10). 
In group (C) which treated with 14% saturated fats for three months heart 
showed hyalinization of cardiac muscles fiber (fig.11), edema and 
infiltration of RBCs in the heart muscle (fig.12). The wall of the blood 
vessels were thickened (fig.13).There was mild mononuclear cellular 
infiltration with zenker necrosis (fig.14). 
The liver in group (C) showed vacuolization of hepatic cytoplasm, 
congestions of veins and dilatation of sinusoids (fig.15). Also there was 
bile duct proliferation (fig.16), kuffer cells were prominent (fig.17) and 
congestion of central veins and extra hepatic hemopoisis were evident 
(fig.18). In addition there was focal infiltration of inflammatory cells and 
necrosis. 
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Fig (6): The heart from rats in  
group (B) showed edema of  
cardiac muscle(1) and zenker     
necrosis (2). 
 
Fig (7): Cardiac muscle from rats in 
group (B) showed increased thickness  
of  blood vessels.  
 
Fig (8): The heart from rats in  
group (B) showed cholesterol cleft.  
1
2
 
The heart from rats in group (A) 
Heart section from rats in group(A) 
 
Heart section from rats in group (A) 
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Fig (9): The liver from rats in group  
(B) showed vacuolization.  
 
Fig (10): The liver from rats in group  
(B) notice sinusoid dilatation (1), necrosis   
(2) and disorganization of cells.  
  
Fig (11): Cardiac muscles fiber from  
rats in group (C) notice hyalinization  
and loss of nuclei.  
1
2
 
Liver section from rats in group (A) 
 
Liver section from rats in group (A) 
 
Heart section from rats in group (A) 
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Fig (12): Heart muscle from rats in  
group (C) notice edema (1), necrosis(2) 
and infiltration of RBCs (3). 
 
 Fig (13): Cardiac muscles from rats  
in group (C) notice the wall of the  
blood vessels were thickened (1), zenker 
necrosis (2) and edema of muscles (3). 
 
Fig (14): Heart muscles from rats in  
group (C) notice the mild mononuclear 
 cellular infiltration (1) with zenker necrosis (2). 
1
2
3
12
3
1 
2
 
Heart section from rats in group (A) 
 
Heart section from rats in group (A) 
 
Heart section from rats in group (A) 
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Fig (15): Liver from rats in group (C)  
showed vacuolization (1) and congestion (2).  
 
Fig (16): Liver from rats in group (C)  
notice bile duct proliferation. 
 
Fig (17): The liver from rats in group (C)  
showed prominent kuffer cells.  
2
1
 
Liver section from rats in group (A) 
 
Liver section from rats in group (A) 
 
Liver section from rats in group (A) 
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Fig (18): liver from rats evident in group  
(C) notice congestion of central veins (1) 
and extra hepatic hemopoisis (2). 
 
 
1
2
 
Liver section from rats in group (A) 
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CHAPTER FOUR 
DISSCUSION 
 
This study was carried out to evaluate the effect of feeding 
cholesterol versus feeding saturated fats on plasma levels of total 
cholesterol, low density lipoprotein-cholesterol (LDL-C), high density 
lipoprotein-cholesterol (HDL-C), very low density lipoprotein-cholesterol 
(VLDL-C) and triglycerides in Westar albino rats and also to evaluate 
histopathological changes on heart and liver. 
4.1 The effect of feeding high cholesterol diet or high saturated fats 
diet on blood cholesterol level in rats 
 
4.1.1 Plasma total cholesterol (TC) 
The results showed that the plasma total cholesterol level 
reported significantly higher level (P< 0.05) following administration of 
2% cholesterol powder mixed with the basal diet after first, second and 
third month in group B compared to group A (control group). These 
results were in agreement with the study of Sharma (1984), who reported 
that administration of 1% cholesterol powder resulted in an increase in 
total cholesterol. Also the results were in line with the result obtained by 
Shela et al. (2005) who reported that administration of 1% cholesterol 
powder to rabbits resulted in an increase total cholesterol. 
The group fed 14% saturated fats mixed with the basal diet (group C) 
showed no significant differences in the total cholesterol after first, 
second and third month compared to group A (control group). These 
results were in agreement with the study of Bonanome and Grundy 
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(1988), who reported that there was inability of stearic acid (saturated FA) 
to raise serum cholesterol concentration. In contrast to insignificant effect 
of feeding saturated fats on total cholesterol in this study Cater et al. 
(1997) reported that palm oil and oleic acid raise serum cholesterol 
concentration. Also Mensink et al. (2003) reported that saturated fats 
boost total cholesterol by elevating harmful LDL. A 2003 meta-analysis 
published in the American Journal of Clinical Nutrition concluded that 
diets high in saturated fat negatively affected cholesterol profiles (Abbey 
et al., 1994). Sylven and Borgstrom (1969) reported that the effects of a 
diet of 10% homogeneous 12 to 18-carbon chain saturated fatty acids 
(lauric, myristic, palmitic and stearic acid) on plasma cholesterol was 
significantly increased only with lauric acid and the variation in these 
results may be due to that long  chain saturated fatty acid has no effect on 
plasma cholesterol. This might suggest that fats used in the present study 
are rich in long chain saturated fatty acid, so plasma cholesterol of the rats 
was not altered. 
4.1.2 Plasma LDL-cholesterol (LDL-C) 
The plasma LDL-C levels were significantly increased (P< 0.05) 
following administration of 2% cholesterol powder mixed with the basal 
diet after the first, second and third month in group B compared to group 
A (control group). These results were in agreement with the study of 
Sharma (1984), who reported that administration of 1% cholesterol 
powder resulted in an increase in LDL-C. In support of the present results, 
Shela et al. (2005) reported that administration of 1% cholesterol powder 
to rabbits resulted in an increase LDL-C. 
On the other hand plasma LDL cholesterol showed no significant 
differences following administration of 14% saturated fats mixed with the 
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basal diet after first, second and third month in group C compared to 
group A (control group). These results were in agreement with the study 
of Bonanome and Grundy (1988), who said that there was inability of 
stearic acid (saturated FA) to raise serum LDL-C concentration. In 
contrast to insignificant effect of feeding saturated fats on LDL-C in this 
study Cater et al (1997) reported that palm oil and oleic acid raise humans 
serum LDL-C concentration. Also Mensink et al (2003) reported that 
saturated fats elevate harmful LDL in humans. 
The variation in the results of LDL-C in the studies mentioned above may 
be due to that carbon chain length of a saturated fatty acid has long been 
suspected to be an important determinant of its cholesterol raising 
potential (Keys et al; 1965). Since in the present study plasma LDL-
cholesterol was not altered, then the fats used could be rich of long chain 
saturated fatty acid.  
4.1.3 Plasma HDL- cholesterol (HDL-C) 
The results in the present work showed that the plasma HDL-C 
levels were significantly decreased (P< 0.05) following administration of 
2% cholesterol powder mixed with the basal diet after the second month 
in group B compared to group A (the control group). These results were in 
agreement with the study of Sharma (1984), who reported that 
administration of 1% cholesterol powder resulted in decrease in LDL-C. 
In support of the present results, Shela et al. (2005) reported that 
administration of 1% cholesterol powder to rabbits resulted in decrease in 
HDL-C. 
However after the first and third month results reported levels of the 
plasma HDL-C significantly (P< 0.05) higher than the control group. 
Since rats in the present study were subjected to relatively long period of 
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treatment, three months, then one can suggest that the time factor is very 
important when data is evaluated for the effect of feeding high cholesterol 
diet to an experimental animal on HDL-C level. 
The plasma HDL cholesterol showed no significant differences following 
administration of 14% saturated fats mixed with the basal diet after first, 
second and third month in group C compared to group A (the control 
group). These results were in agreement with the study of Bonanome and 
Grundy (1988), who said that there was inability of stearic acid (saturated 
FA) to raise serum HDL-C concentrations. However compared to the 
insignificant effect of feeding saturated fats on HDL-C in this study, 
Schaefer et al (1981) have presented evidence that an extremely low fat 
diet caused significant (P < 0.01) decreases in plasma HDL-C in 
normolipidemic young subjects. Also these results disagree with Mensink 
et al. (2003) who concluded that long chain saturated fatty acids such as 
lauric acid increase HDL cholesterol levels. 
The variation in the results of HDL-C in the studies mentioned above may 
be due to chain length of a saturated fatty acid which has long been 
suspected to be an important determinant of its cholesterol raising 
potential (Keys et al; 1965). Since in this study long chain saturated fatty 
acid could be used, then plasma HDL-cholesterol was not altered. 
 
4.1.4 Plasma VLDL-cholesterol (VLDL-C) 
Plasma VLDL-C levels after the first and the second month 
showed significantly (P< 0.05) lower levels following administration of 
2% cholesterol powder mixed with the basal diet in group B compared to 
group A (the control group). These results were in agreement with the 
study of Jelske et al (2009) who reported that mice under condition of 
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feeding a cholesterol-enriched diet (1%) for two weeks resulted in lower 
levels of VLDL cholesterol. However the levels in group (B) returned to a 
similar value of the control group after three months. 
Whereas administration of 14% saturated fats mixed with the basal diet 
resulted in no significant differences after first, second and third month in 
group C compared to group A (the control group). These results were in 
line with the result obtained by Mattson and Grundy (1985) who reported 
that VLDL cholesterol was not altered after consuming a liquid diet in 
which the predominant fatty acids were saturated. 
4.2 The effect of feeding high cholesterol diet or high saturated fats 
diet on blood triglycerides level in rats: 
The plasma TAG levels were significantly (P< 0.05) decreased 
following administration of 2% cholesterol powder mixed with the basal 
diet in group B compared to group A (the control group) this observed 
after tow months, but after the third month the level in group (B) scored 
similar level to the control group. These results were in line with those 
obtained by Grefhorst et al. (2002) who observed that the hepatic free 
cholesterol and cholesteryl ester accumulation in cholesterol-fed mice was 
accompanied by extremely low plasma levels of triglycerides. But these 
results disagree with Conner (1961) who said that our results showed a 
lack of any significant effect of dietary cholesterol on plasma lipids in 
normolipidemic men. The differences reported concerning the changes in 
the TAG in previous studies, could be due to the difference in the length 
of the periods of application of treatment.  
The plasma TAG levels showed no significant differences following 
administration of 14% saturated fats mixed with the basal diet after first, 
second and third month in group C compared to group A (the control 
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group). These results were consistent with result reported by Mattson and 
Grundy (1985) who said that twenty patients consumed a liquid diet in 
which the predominant fatty acids was  saturated, twelve of the patients 
had normal TG levels and eight patients had hypertriglyceridemia. 
 
4.3 Histopathological Findings 
 
4.3.1 The effect of feeding high cholesterol diet or high saturated 
fats diet on heart tissues 
 
The heart samples in group fed 2% cholesterol (group B) when 
examined, showed zenker necrosis, hyalinization, edema of cardiac 
muscle, increased thickness of blood vessels and presence of cholesterol 
cleft. These findings were in agreement with the study of Ludwig et al. 
(1991) who reported that high dietary cholesterol in young rabbits caused 
an increase in intimal-plus-medial thickness from 0.31 mm and 0.33 mm 
to 0.88 mm and 0.89 mm, respectively. Also the findings in the present 
study were in line with findings obtained by Lutgens et al. (1999) who 
reported that mice fed high cholesterol develop atherosclerotic lesions 
resembling those found in humans, depending on their plasma cholesterol 
levels. Also in a study investigated whether the ACAT inhibitor 
avasimibe can reduce atherogenesis independently of its cholesterol-
lowering effect in ApoE*3-Leiden mice, before start this study, mice were 
fed high cholesterol diet for 3 weeks and reported accumulation of free 
cholesterol in atherosclerotic lesions (Dianne et al; 2001). 
 56 
 
Whereas heart samples in the group fed 14% saturated fats (group C) 
showed hyalinization of cardiac muscles fiber, edema and infiltration of 
RBCs in the heart muscle, the wall of the blood vessels were thickened 
and there is mild mononuclear cellular infiltration with zenker necrosis. 
These findings were in line with those obtained by Hans and Ruth (1973) 
who observed that some heart sections of rats fed saturated medium chain 
triglycerides, when stained with Light Green SF Yellowish revealed areas 
of muscle fibrils that did not accept the stain, probably as a consequence 
of cellular damage.  
4.3.2 The effect of feeding high cholesterol diet or high saturated 
fats diet on liver 
  
The liver samples in the group fed 2% cholesterol (group B) 
showed vacuolization, dilatation of sinusoid, necrosis and disorganization 
of hepatocytes. These findings were in agreement with the study of 
Wanless et al. (1996) who said Rabbits when given a cholesterol- 
supplemented diet (1%) developed sinusoidal and portal fibrosis lipid 
droplets in hepatocytes. Also this findings in the present work were in 
agreement with the study of Hausner et al. (1995) who showed that 
cholesterol supplemented diet caused high plasma cholesterol level with 
hepatic cell degeneration. Also Elaine et al. (1972) reported that 
histologic examination of sections of livers showed fat infiltration of 
hepatic cells and a greater damage to the liver cells was noted when 
cholesterol was added to the basal diet of male rats. 
Hypercholesterolemia is said to contribute to hepatic injury as a result of 
cholesterol accumulation. Lack of underlying basement membranes 
facilitates the flow of LDL cholesterol in circulating plasma between 
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sinusoidal lumen and hepatocytes, because in normal liver sinusoids are 
limited by fenestrated endothelial cells (Burt, 1993). The normal liver 
tissue has cholesterol oxidase. Cholesterol generates cholesterol oxidation 
products and free radicals by cholesterol oxidase. Cholesterol oxides 
include cytotoxic and steatotic effects (Aviram, 1992). Lipid 
accumulation leads to oxidative stress in hepatic tissue. The oxidative 
stress may contribute to peroxidation of LDL. These peroxidative fatty 
acids and reactive oxygen species induce hepatic damage (Britton and 
Bacon, 1994). 
Whereas in the group fed 14% saturated fats (group C), showed 
vacuolization of hepatic cytoplasm, congestions of veins, dilatation of 
sinusoids, bile duct proliferation, kuffer cells were prominent, congestion 
of central veins and extra hepatic hemopoisis and focal infiltration of 
inflammatory cells and necrosis. These findings were in agreement with 
the study of Ramachandran et al. (2006) who reported that when a 
computed diet based on cereals and spices incorporated with saturated fats 
fed to albino rats, histopathological examination of liver tissue in 
particular showed mild cytoplasmic vacuolation. Also Hans and Ruth 
(1973) found that when male rats fed saturated medium chain 
triglycerides, many livers revealed marked proliferation of bile ducts.  
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CONCLUSIONS AND RECOMMENDATIONS 
 
The results obtained from this work, indicated that high dietary 
cholesterol affect plasma lipid profile concentration while feeding high 
saturated fats did not. On the other hand histopathological findings 
indicated that both high dietary cholesterol and high dietary saturated fats 
showed clear histopathological changes in tissues of the heart and liver. 
As several studies beside this study have confirmed that a high 
consumption of saturated fatty acids and cholesterol have a high incidence 
of changes in liver and heart, there is an official recommendation for a 
minimum daily intake of cholesterol and saturated fats (intake levels that 
meet the needs of health).  
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